Table 4

Estimates for clinically relevant thresholds for improvement and deterioration on the CAT

CATT3–T0T6–T0T12–T0Weighted threshold
 ChangeImprovementDeteriorationImprovementDeteriorationImprovementDeteriorationImprovementDeterioration
Minimal change
 Anchor-based PR (n)1073696428843291121
 Anchor-based PR−2.742.71−2.733.21−2.804.21−2.753.42
 Anchor-based RCP (n)1227143618463282
 Anchor-based RCP−2.861.97−3.781.63−3.381.78
 Distribution-based PR (n)227127184135180129591391
 Distribution-based PR−2.292.10−2.172.05−2.332.11−2.262.09
 Distribution-based RCP (n)1028381917986262260
 Distribution-based RCP−1.671.83−1.531.44−1.581.30−1.601.52
Moderate change
 Anchor-based PR (n)519457371013317
 Anchor-based PR−5.02−3.298.14−4.276.30−4.237.06
 Anchor-based RCP (n)58129599
 Anchor-based RCP3.893.89
Large change
 Anchor-based PR (n)16312214342
 Anchor-based PR−4.19−7.00−6.07−5.62
 Anchor-based RCP (n)430294134
 Anchor-based RCP−6.00−4.225.75−4.775.75
No change
 Anchor-based PR (n)133115114362
 Anchor-based PR0.03−0.01−0.33−0.10
 Anchor-based RCP (n)14111383337
 Anchor-based RCP−0.16−0.54−0.47−0.36
  • Data reported as clinically relevant threshold or n. Negative change represents improvement for all health status instruments. Paired t-tests were applied with significance level at p<0.05. Non-significant results were excluded, except for the ‘No change’ group.

  • CAT, COPD Assessment Test; n, number of patients; PR, pulmonary rehabilitation; RCP, routine clinical practice; T0, baseline measurement; T3, 3-month follow-up; T6, 6-month follow-up; T12, 12-month follow-up.